Colon cancer screening continues as pivotal to cancer prevention.

UC San Diego Moores Cancer Center, the only NCI-designated Comprehensive Cancer Center in the San Diego region, was established in 1978. It has 13 disease teams and subspecialty cancer care programs that include surgical oncology, medical oncology, gynecologic oncology, radiation oncology, minimally invasive surgery, interventional radiology, molecular cancer imaging, palliative care, integrative medicine, psychiatry, psychology, and nutrition, as well as 15 National Academy of Sciences members, a Nobel laureate and a Breakthrough Prize recipient. The hallmark of Moores Cancer Center is leveraging its world-class research, in collaboration with prominent basic science institutions in the region, to rapidly translate scientific advances into new, leading-edge personalized treatments for patients. Scott M. Lippman, MD (second photo on cover), is director of Moores Cancer Center, senior associate dean, and associate vice chancellor for cancer research and care at UC San Diego. He has more than 25 years of experience as principal investigator of clinical and translational research involving genetic drivers of head and neck and lung carcinogenesis as well as molecular-targeted trials in cancer prevention and therapy. NCCN Guidelines® Insights